160 related articles for article (PubMed ID: 36047971)
1. SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis.
Zhan F; Deng Q; Chen Z; Xie C; Xiang S; Qiu S; Tian L; Wu C; Ou Y; Chen J; Xu L
Cancer Sci; 2022 Dec; 113(12):4104-4119. PubMed ID: 36047971
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
[TBL] [Abstract][Full Text] [Related]
3. Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy.
Zhang F; Yan T; Guo W; Sun K; Wang S; Bao X; Liu K; Zheng B; Zhang H; Ren T
J Exp Clin Cancer Res; 2018 Jul; 37(1):135. PubMed ID: 29970115
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
5. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing RhoA/ROCK1 Signaling Pathway.
Liu JL; Li J; Xu JJ; Xiao F; Cui PL; Qiao ZG; Chen XD; Tao WD; Zhang XL
Mol Pharmacol; 2019 Apr; 95(4):451-461. PubMed ID: 30674565
[TBL] [Abstract][Full Text] [Related]
6. RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway.
Zhan F; He T; Chen Z; Zuo Q; Wang Y; Li Q; Zhong S; Ou Y
Cell Biosci; 2021 Oct; 11(1):179. PubMed ID: 34627383
[TBL] [Abstract][Full Text] [Related]
7. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of anlotinib-induced autophagy attenuates invasion and migration by regulating epithelial-mesenchymal transition and cytoskeletal rearrangement through ATG5 in human osteosarcoma cells.
Zheng B; Sun X; Zhang L; Qu G; Ren C; Yan P; Zhou C; Yue B
Braz J Med Biol Res; 2024; 57():e13152. PubMed ID: 38381883
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract][Full Text] [Related]
10. Circ_SAR1A regulates the malignant behavior of lung cancer cells via the miR-21-5p/TXNIP axis.
Zhao Y; Wan Y; He T
J Clin Lab Anal; 2022 May; 36(5):e24366. PubMed ID: 35334496
[TBL] [Abstract][Full Text] [Related]
11. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide Induces Autophagic Cell Death and Inhibits Invasion and Metastasis of Human Osteosarcoma Cells in An Autophagy-Dependent Manner.
Liu Y; Zhang Y; Zou J; Yan L; Yu X; Lu P; Wu X; Li Q; Gu R; Zhu D
Cell Physiol Biochem; 2017; 44(4):1396-1410. PubMed ID: 29197865
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.
Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E
Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486
[TBL] [Abstract][Full Text] [Related]
14. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
15. Pull down assay for GTP-bound form of Sar1a reveals its activation during morphological differentiation.
Urai Y; Yamawaki M; Watanabe N; Seki Y; Morimoto T; Tago K; Homma K; Sakagami H; Miyamoto Y; Yamauchi J
Biochem Biophys Res Commun; 2018 Sep; 503(3):2047-2053. PubMed ID: 30078678
[TBL] [Abstract][Full Text] [Related]
16. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
17. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
18. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
Berlanga P; Muñoz L; Piqueras M; Sirerol JA; Sánchez-Izquierdo MD; Hervás D; Hernández M; Llavador M; Machado I; Llombart-Bosch A; Cañete A; Castel V; Font de Mora J
Mol Oncol; 2016 Aug; 10(7):1043-53. PubMed ID: 27155790
[TBL] [Abstract][Full Text] [Related]
19. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
20. Acetylation dependent functions of Rab22a-NeoF1 Fusion Protein in Osteosarcoma.
Liang X; Wang X; He Y; Wu Y; Zhong L; Liu W; Liao D; Kang T
Theranostics; 2020; 10(17):7747-7757. PubMed ID: 32685017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
